Robert Bradley Paull

Insider Reports History

Location
Waltham, MA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Bradley Paull:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kala Pharmaceuticals, Inc. Director Common Stock 40,000 $269,600 $6.74 17 Jun 2021 Direct
Kala Pharmaceuticals, Inc. Director Common Stock 2,361 $15,913 $6.74 17 Jun 2021 Indirect
Kala Pharmaceuticals, Inc. Director Stock Option (right to buy) 40,000 16 Jun 2022 Direct

Insider Reports Filed by Robert Bradley Paull

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALA Kala Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:45
KALA Kala Pharmaceuticals, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:30